TripSit · MXE

正文中文为机器翻译，仅供参考；专业内容以折叠的原文为准。

详情

别名

methoxetamine 3-meo-2'oxo-pce

分类

解离剂 research-chemical 习惯形成

相互作用

2c-t-x

风险等级

谨慎 （Caution）

2c-x

风险等级

低风险 · 协同 （Low Risk & Synergy）

5-meo-xxt

备注

关于这种组合的信息很少。

查看原文

Little information exists about this combination.

风险等级

低风险 · 协同 （Low Risk & Synergy）

alcohol

备注

这种组合存在记忆丧失、呕吐和严重共济失调的高风险。

查看原文

There is a high risk of memory loss, vomiting and severe ataxia from this combination.

风险等级

危险（应避免） （Dangerous）

amphetamines

备注

心动过速、高血压和躁狂状态的风险

查看原文

Risk of tachycardia, hypertension, and manic states

风险等级

谨慎 （Caution）

amt

风险等级

危险（应避免） （Dangerous）

benzodiazepines

备注

这两种物质都会增强另一种物质引起的共济失调和镇静作用，高剂量时可能会导致意外的意识丧失。将受影响的人置于恢复位置，以防止吸入过量呕吐物。

查看原文

Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. Place the affected individual in the recovery position to prevent vomit aspiration from excess.

风险等级

谨慎 （Caution）

caffeine

备注

没有可能的相互作用

查看原文

No likely interactions

风险等级

Low Risk & No Synergy

cannabis

风险等级

低风险 · 协同 （Low Risk & Synergy）

cocaine

备注

与 MXE 一起服用的兴奋剂更容易导致过度躁狂状态，尤其是在避免睡眠的情况下。

查看原文

Stimulants taken with MXE can lead to hypermanic states much more easily, especially if sleep is avoided.

风险等级

谨慎 （Caution）

dextromethorphan

备注

由于 DXM 和 MXE 都是 SRI，因此将 DXM 与 MXE 结合使用时存在血清素综合征的风险。 MXE 和 DXM 对血清素转运蛋白具有显着的亲和力。

查看原文

There is a risk of serotonin syndrome when combining DXM with MXE, due to DXM and MXE both being SRI’s. MXE and DXM having notable affinities for the serotonin transporter.

来源

author

Bryan L. Roth, Simon Gibbons, Warunya Arunotayanun, Xi-Ping Huang, Vincent Setola, Ric Treble, Les Iversen

标题

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor

链接

https://doi.org/10.1371/journal.pone.0059334

author

Matteo Marti, Giuseppe Talani, Cristina Miliano, Sabrine Bilel, Francesca Biggio, Jessica Bratzu, Marco Diana, Maria Antonietta De Luca, Liana Fattore

标题

New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat

链接

https://doi.org/10.1016/j.expneurol.2021.113836

author

Laura Hondebrink, Emma E.J. Kasteel, Anke M. Tukker, Fiona M.J. Wijnolts, Anouk H.A. Verboven, Remco H.S. Westerink

标题

Neuropharmacological characterization of the new psychoactive substance methoxetamine

链接

https://doi.org/10.1016/j.neuropharm.2017.04.035

author

Linda L. Werling, Ashleigh Keller, Julie G. Frank, Samer J. Nuwayhid

标题

A comparison of the binding profiles of dextromethorphan, memantine, fluoxetine and amitriptyline: Treatment of involuntary emotional expression disorder

链接

https://doi.org/10.1016/j.expneurol.2007.06.013

author

Linda Nguyen, Kelan L. Thomas, Brandon P. Lucke-Wold, John Z. Cavendish, Molly S. Crowe, Rae R. Matsumoto

标题

Dextromethorphan: An update on its utility for neurological and neuropsychiatric disorders

链接

https://doi.org/10.1016/j.pharmthera.2016.01.016

风险等级

不安全 （Unsafe）

diphenhydramine

备注

这种组合导致血清素综合征的风险很高。这两种物质都会增强另一种物质引起的共济失调和镇静作用，高剂量时可能会导致意外的意识丧失。在失去知觉时，如果不处于恢复姿势，则有呕吐物误吸的风险。较高剂量的 MXE 很可能会增加 DPH 的谵妄作用，并可能大大增加受伤、躁狂和精神病的风险。医疗剂量不太可能引起关注。

查看原文

There is a high risk of serotonin syndrome from this combination. Both substances potentiate the ataxia and sedation caused by the other and can lead to unexpected loss of consciousness at high doses. While unconscious, vomit aspiration is a risk if not placed in the recovery position. MXE has a high likelihood of increasing DPH's deliriant effects at higher dosages and can greatly increase the risk of injury, mania, and psychosis. Medical dosages are unlikely to be of concern.

来源

author

Clark, J. H., Meltzer, E. O., & Naclerio, R. M. (2025)

标题

Diphenhydramine: It is time to say a final goodbye. World Allergy Organization Journal, 18(2), 101027.

链接

https://doi.org/10.1016/j.waojou.2025.101027

author

Ener, R. A., Meglathery, S. B., Decker, W. A. V., & Gallagher, R. M. (2003)

标题

Serotonin Syndrome and Other Serotonergic Disorders: Table 1. Pain Medicine, 4(1), 63–74.

链接

https://doi.org/10.1046/j.1526-4637.2003.03005.x

author

Marti, M., Talani, G., Miliano, C., Bilel, S., Biggio, F., Bratzu, J., Diana, M., De Luca, M. A., & Fattore, L. (2021)

标题

New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology, 345, 113836.

链接

https://doi.org/10.1016/j.expneurol.2021.113836

author

Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X.-P., Setola, V., Treble, R., & Iversen, L. (2013)

标题

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor. PLoS ONE, 8(3), e59334.

链接

https://doi.org/10.1371/journal.pone.0059334

author

Varghese, E., Abate, M. A., Hu, L., Kaplan, J., Kraner, J., Long, D. L., Sorg, M., Mock, A., Greenwald, M., & Andrew, T. (2015)

标题

Characterization of Diphenhydramine-Related Accidental Overdose Deaths. Academic Forensic Pathology, 5(1), 105–115.

链接

https://doi.org/10.23907/2015.011

风险等级

危险（应避免） （Dangerous）

dmt

风险等级

低风险 · 协同 （Low Risk & Synergy）

dox

备注

作为 NMDA 拮抗剂，MXE 会增强 DOx，其强度可能会令人不快

查看原文

As an NMDA antagonist MXE potentiates DOx which can be unpleasantly intense

风险等级

谨慎 （Caution）

ghb/gbl

备注

这两种物质都会导致共济失调，并带来呕吐和意识不清的风险。如果个体在醉酒状态下失去知觉，且不采取恢复姿势，则存在严重的呕吐物误吸风险。

查看原文

Both substances cause ataxia and bring a risk of vomiting and unconsciousness. If the individual falls unconscious while under the influence there is a severe risk of vomit aspiration if they are not placed in the recovery position.

风险等级

危险（应避免） （Dangerous）

ketamine

风险等级

低风险 · 协同 （Low Risk & Synergy）

lithium

备注

将锂与 MXE 联合使用时，存在发生血清素综合征的风险，因为锂与其他血清素能药物一起使用可诱发血清素综合征，而 MXE 对血清素转运蛋白表现出显着的亲和力。

查看原文

There is a risk of serotonin syndrome when combining Lithium with MXE, as Lithium can induce serotonin syndrome in conjunction with other serotonergic drugs, and MXE has shown a notable affinity for the serotonin transporter.

来源

author

Lenox, R. H., & Hahn, C. G.

标题

Overview of the mechanism of action of lithium in the brain: fifty-year update (2000)

链接

https://pubmed.ncbi.nlm.nih.gov/10826655/

author

Shahani, L.

标题

Venlafaxine Augmentation With Lithium Leading to Serotonin Syndrome (2012)

链接

https://doi.org/10.1176/appi.neuropsych.11080196

author

DeBattista, C., Sofuoglu, M., & Schatzberg, A. F.

标题

Serotonergic synergism: the risks and benefits of combining the selective serotonin reuptake inhibitors with other serotonergic drugs (1998)

链接

https://doi.org/10.1016/S0006-3223(98)00161-9

author

Massot, O.

标题

5-HT1B Receptors: A Novel Target for Lithium: Possible Involvement in Mood Disorders (1999)

链接

https://doi.org/10.1016/S0893-133X(99)00042-1

author

Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X.-P., Setola, V., Treble, R., & Iversen, L.

标题

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor (2013)

链接

https://doi.org/10.1371/journal.pone.0059334

author

Marti, M., Talani, G., Miliano, C., Bilel, S., Biggio, F., Bratzu, J., Diana, M., De Luca, M. A., & Fattore, L.

标题

New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat (2021)

链接

https://doi.org/10.1016/j.expneurol.2021.113836

风险等级

危险（应避免） （Dangerous）

lsd

风险等级

低风险 · 协同 （Low Risk & Synergy）

maois

备注

MAO-B 抑制剂似乎可以增加 MXE 的效力。 MAO-A 抑制剂有一些与该组合相关的负面报告，但没有太多可用信息

查看原文

MAO-B inhibitors appear to increase the potency of MXE. MAO-A inhbitors have some negative reports associated with the combination but there isn't much information available

风险等级

不安全 （Unsafe）

mdma

备注

有报道称，当两者同时服用时，会产生危险的血清素相互作用，但在 MDMA 体验结束时服用 MXE 似乎不会引起同样的问题。

查看原文

There have been reports of risky serotonergic interactions when the two are taken at the same time, but MXE taken to the end of an MDMA experience does not appear to cause the same issues.

风险等级

谨慎 （Caution）

mescaline

风险等级

低风险 · 协同 （Low Risk & Synergy）

mushrooms

风险等级

低风险 · 协同 （Low Risk & Synergy）

nbomes

备注

作为 NMDA 拮抗剂，MXE 会增强 NBOMes，其强度可能会令人不快

查看原文

As an NMDA antagonist MXE potentiates NBOMes which can be unpleasantly intense

风险等级

谨慎 （Caution）

nitrous

风险等级

低风险 · 协同 （Low Risk & Synergy）

opioids

备注

这种组合可以增强阿片类药物的作用

查看原文

This combination can potentiate the effects of the opioid

风险等级

危险（应避免） （Dangerous）

pcp

备注

没有关于此组合的报告

查看原文

There are no reports available about this combination

风险等级

谨慎 （Caution）

pregabalin

备注

普瑞巴林和 MXE 可能会协同作用并增加彼此的负面副作用，例如恶心、头晕和意识丧失。由于癫痫发作的担忧，建议谨慎使用任何高于低剂量的剂量，以及针对癫痫发作风险较高和/或行为的个体的所有剂量。

查看原文

Pregabalin and MXE may synergize and increase each other’s negative side effects such as nausea, dizziness, and loss of consciousness. Caution is advised for anything above low dosages due to seizure concerns, and all dosages for individuals with higher risk seizure profiles and or behavior.

来源

author

Anwar, S., Cooper, J., Rahman, J., Sharma, C., & Langford, R. (2019)

标题

Prolonged Perioperative Use of Pregabalin and Ketamine to Prevent Persistent Pain after Cardiac Surgery. Anesthesiology, 131(1), 119–131.

链接

https://doi.org/10.1097/ALN.0000000000002751

author

Arendt-Nielsen, L., Mansikka, H., Staahl, C., Rees, H., Tan, K., Smart, T. S., Monhemius, R., Suzuki, R., & Drewes, A. M. (2011)

标题

A Translational Study of the Effects of Ketamine and Pregabalin on Temporal Summation of Experimental Pain: Regional Anesthesia and Pain Medicine, 36(6), 585–591.

链接

https://doi.org/10.1097/AAP.0b013e31822b0db0

author

Barker-Haliski, M., & White, H. S. (2015)

标题

Glutamatergic Mechanisms Associated with Seizures and Epilepsy. Cold Spring Harbor Perspectives in Medicine, 5(8), a022863.

链接

https://doi.org/10.1101/cshperspect.a022863

author

Ben‐Menachem, E. (2004)

标题

Pregabalin Pharmacology and Its Relevance to Clinical Practice. Epilepsia, 45(s6), 13–18.

链接

https://doi.org/10.1111/j.0013-9580.2004.455003.x

author

French, J., Kwan, P., Fakhoury, T., Pitman, V., DuBrava, S., Knapp, L., & Yurkewicz, L. (2014)

标题

Pregabalin monotherapy in patients with partial-onset seizures: A historical-controlled trial. Neurology, 82(7), 590–597.

链接

https://doi.org/10.1212/WNL.0000000000000119

author

Gayatri, N., & Livingston, J. (2006)

标题

Aggravation of epilepsy by anti‐epileptic drugs. Developmental Medicine & Child Neurology, 48(5), 394–398.

链接

https://doi.org/10.1017/S0012162206000843

author

Hitchings, A. W. (2016)

标题

Drugs that lower the seizure threshold. Adverse Drug Reaction Bulletin, 298(1), 1151–1154.

链接

https://doi.org/10.1097/FAD.0000000000000016

author

Isoardi, K. Z., Polkinghorne, G., Harris, K., & Isbister, G. K. (2020)

标题

Pregabalin poisoning and rising recreational use: a retrospective observational series. British Journal of Clinical Pharmacology, 86(12), 2435–2440.

链接

https://doi.org/10.1111/bcp.14348

author

Kumar, N., Laferriere, A., Yu, J. S. C., Leavitt, A., & Coderre, T. J. (2010)

标题

Evidence that pregabalin reduces neuropathic pain by inhibiting the spinal release of glutamate. Journal of Neurochemistry, 113(2), 552–552.

链接

https://doi.org/10.1111/j.1471-4159.2010.06625.x

author

Marti, M., Talani, G., Miliano, C., Bilel, S., Biggio, F., Bratzu, J., Diana, M., De Luca, M. A., & Fattore, L. (2021)

标题

New insights into methoxetamine mechanisms of action: Focus on serotonergic 5-HT2 receptors in pharmacological and behavioral effects in the rat. Experimental Neurology, 345, 113836.

链接

https://doi.org/10.1016/j.expneurol.2021.113836

author

Martinez, V., Cymerman, A., Ben Ammar, S., Fiaud, J. F., Rapon, C., Poindessous, F., Judet, T., Chauvin, M., Bouhassira, D., Sessler, D., Mazoit, X., & Fletcher, D. (2014)

标题

The analgesic efficiency of combined pregabalin and ketamine for total hip arthroplasty: a randomised, double‐blind, controlled study. Anaesthesia, 69(1), 46–52.

链接

https://doi.org/10.1111/anae.12495

author

Roth, B. L., Gibbons, S., Arunotayanun, W., Huang, X.-P., Setola, V., Treble, R., & Iversen, L. (2013)

标题

The Ketamine Analogue Methoxetamine and 3- and 4-Methoxy Analogues of Phencyclidine Are High Affinity and Selective Ligands for the Glutamate NMDA Receptor. PLoS ONE, 8(3), e59334.

链接

https://doi.org/10.1371/journal.pone.0059334

author

Slocum, G. W., Schult, R. F., Gorodetsky, R. M., Wiegand, T. J., Kamali, M., & Acquisto, N. M. (2018)

标题

Pregabalin and paradoxical reaction of seizures in a large overdose. Toxicology Communications, 2(1), 19–20.

链接

https://doi.org/10.1080/24734306.2018.1458465

author

Zhou, Y., Sun, W., Fu, Y., Wang, J., Fan, J., Liang, Y., Jia, W., & Han, R. (2024)

标题

Effect of esketamine combined with pregabalin on acute postsurgical pain in patients who underwent resection of spinal neoplasms: a randomized controlled trial. Pain, 165(9), e96–e105.

链接

https://doi.org/10.1097/j.pain.0000000000003211

风险等级

谨慎 （Caution）

ssris

备注

根据 SSRI，这种组合可能是不可预测的

查看原文

Depending on the SSRI this combination can be unpredictable

风险等级

谨慎 （Caution）

tramadol

风险等级

危险（应避免） （Dangerous）

剂量说明

NOTE: Bodyweight plays a slight factor in MXE dosing, these are values for a 175lb (80kg) male

后遗时间

2-48 小时

剂量

鼻吸

常规

20-35mg

重剂量

60mg+

轻度

10-20mg

强效

35-60mg

阈值

5-10mg

口服

常规

25-35mg

轻度

15-25mg

强效

40-65mg

阈值

10-15mg

舌下

常规

40-60mg

轻度

10-20mg

强效

60-75mg

阈值

5-10mg

持续时间

3-6 小时

相关链接

经验报告

https://www.erowid.org/experiences/subs/exp_Methoxetamine_.shtml

名称

mxe

通用名

MXE

属性

后遗效应

2–48 小时

别名

methoxetamine 3-meo-2'oxo-pce

avoid

CNS depressants such as alcohol, benzodiazepines, and opioids. Additionally substances that have an effect on serotonin such as MDMA, methamphetamine, and dextromethorphan (DXM).

分类

解离剂 research-chemical 习惯形成

剂量

Insufflated Threshold: 5-10mg Light: 10-20mg Common: 20-35mg Strong: 35-60mg Heavy: 60mg+ M-Hole: 70mg+ | Oral Threshold: 10-15mg Light: 15-25mg Common: 25-35 Strong: 40-65mg M-Hole: 75mg+ | Sublingual Threshold: 5-10mg Low: 10-20mg Common: 40-60mg Strong: 60-75mg M-Hole: 75-100mg | NOTE: Bodyweight plays a slight factor in MXE dosing, these are values for a 175lb (80kg) male

持续

3–6 小时

legal

Methoxetamine is scheduled and or controlled in Brazil, Canada, China, EU, Finland, Israel, Japan, Poland, Russia, United Kingdom, United Nations, and the United States (among others).

起效

Insufflated: 5–20 分钟 | Oral: 30–60 分钟 | Sublingual: 15–45 分钟

摘要

A dissociative drug which is an analogue of ketamine. It is reported to be less sedating and more potent by weight. Anectodal reports indicate it has a subjectively more 'complicated' set of effects.

效应

Acuity suppression

https://psychonautwiki.org/wiki/Acuity_suppression

Amnesia

https://psychonautwiki.org/wiki/Amnesia

Analysis enhancement

https://psychonautwiki.org/wiki/Analysis_enhancement

Anxiety suppression

https://psychonautwiki.org/wiki/Anxiety_suppression

Auditory distortion

https://psychonautwiki.org/wiki/Auditory_distortion

Auditory hallucinations

https://psychonautwiki.org/wiki/Auditory_hallucinations

Auditory suppression

https://psychonautwiki.org/wiki/Auditory_suppression

Autonomous entities

https://psychonautwiki.org/wiki/Autonomous_entities

Cognitive euphoria

https://psychonautwiki.org/wiki/Cognitive_euphoria

Compulsive redosing

https://psychonautwiki.org/wiki/Compulsive_redosing

Conceptual thinking

https://psychonautwiki.org/wiki/Conceptual_thinking

Consciousness disconnection

https://psychonautwiki.org/wiki/Consciousness_disconnection

Creativity enhancement

https://psychonautwiki.org/wiki/Creativity_enhancement

Depersonalization

https://psychonautwiki.org/wiki/Depersonalization

Derealization

https://psychonautwiki.org/wiki/Derealization

Disinhibition

https://psychonautwiki.org/wiki/Disinhibition

Dizziness

https://psychonautwiki.org/wiki/Dizziness

Double vision

https://psychonautwiki.org/wiki/Double_vision

Déjà vu

https://psychonautwiki.org/wiki/D%C3%A9j%C3%A0_vu

Environmental cubism

https://psychonautwiki.org/wiki/Environmental_cubism

Environmental orbism

https://psychonautwiki.org/wiki/Environmental_orbism

External hallucinations

https://psychonautwiki.org/wiki/External_hallucinations

Frame rate suppression

https://psychonautwiki.org/wiki/Frame_rate_suppression

Geometry

https://psychonautwiki.org/wiki/Geometry

Immersion enhancement

https://psychonautwiki.org/wiki/Immersion_enhancement

Information processing suppression

https://psychonautwiki.org/wiki/Information_processing_suppression

Internal hallucinations

https://psychonautwiki.org/wiki/Internal_hallucinations

Mania

https://psychonautwiki.org/wiki/Mania

Memory suppression

https://psychonautwiki.org/wiki/Memory_suppression

Motor control loss

https://psychonautwiki.org/wiki/Motor_control_loss

Nausea

https://psychonautwiki.org/wiki/Nausea

Pattern recognition suppression

https://psychonautwiki.org/wiki/Pattern_recognition_suppression

Perception of decreased weight

https://psychonautwiki.org/wiki/Perception_of_decreased_weight

Perspective alterations

https://psychonautwiki.org/wiki/Perspective_alterations

Perspective distortions

https://psychonautwiki.org/wiki/Perspective_distortions

Physical autonomy

https://psychonautwiki.org/wiki/Physical_autonomy

Physical euphoria

https://psychonautwiki.org/wiki/Physical_euphoria

Scenarios and plots

https://psychonautwiki.org/wiki/Scenarios_and_plots

Scenery slicing

https://psychonautwiki.org/wiki/Scenery_slicing

Settings, sceneries, and landscapes

https://psychonautwiki.org/wiki/Settings,_sceneries,_and_landscapes

Spontaneous tactile sensations

https://psychonautwiki.org/wiki/Spontaneous_tactile_sensations

Tactile disconnection

https://psychonautwiki.org/wiki/Tactile_disconnection

Tactile suppression

https://psychonautwiki.org/wiki/Tactile_suppression

Thought deceleration

https://psychonautwiki.org/wiki/Thought_deceleration

Time distortion

https://psychonautwiki.org/wiki/Time_distortion

Unity and interconnectedness

https://psychonautwiki.org/wiki/Unity_and_interconnectedness

Visual disconnection

https://psychonautwiki.org/wiki/Visual_disconnection

Visual sliding

https://psychonautwiki.org/wiki/Visual_sliding

来源

general

Methoxetamine associated reversible cerebellar toxicity: three cases with analytical confirmation. - http://www.ncbi.nlm.nih.gov/pubmed/22578175 Methoxetamine: from drug of abuse to rapid-acting antidepressant. - http://www.ncbi.nlm.nih.gov/pubmed/22819129 From Special K to Special M: the evolution of the recreational use of ketamine and methoxetamine. - http://www.ncbi.nlm.nih.gov/pubmed/23421859 Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn - http://www.ncbi.nlm.nih.gov/pubmed/23774830 Three months of methoxetamine administration is associated with significant bladder and renal toxicity in mice. - http://www.ncbi.nlm.nih.gov/pubmed/24580056 Analytical findings of an acute intoxication after inhalation of methoxetamine. - http://www.ncbi.nlm.nih.gov/pubmed/24904014 Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report - http://www.ncbi.nlm.nih.gov/pubmed/25060403 From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine. - http://www.ncbi.nlm.nih.gov/pubmed/23421859 Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn. - http://www.ncbi.nlm.nih.gov/pubmed/23774830 Acute methoxetamine and amphetamine poisoning with fatal outcome: a case report. - http://www.ncbi.nlm.nih.gov/pubmed/25060403~adddrugsource cannabis general Cannabis use in relation to obesity and insulin resistance in the Inuit population. - https://www.ncbi.nlm.nih.gov/pubmed/25557382 3 case reports of toxicity due to recreational use of MXE - http://link.springer.com/article/10.1007/s00228-011-1199-9

legality

http://www.azleg.gov/DocumentsForBill.asp?Session_ID=112&Bill_Number=HB2453 http://www.leg.state.fl.us/Statutes/index.cfm?App_mode=Display_Statute&URL=0800-0899/0893/0893.html http://www.in.gov/legislative/ic/2010/title35/ar31.5/ch2.html http://www.legis.la.gov/legis/ViewDocument.aspx?d=850979&n=HB10%20Act https://www.revisor.mn.gov/statutes/?id=152.02 http://www.legis.nd.gov/cencode/t19c03-1.pdf?20140721032549 http://www.legislature.state.oh.us/BillText130/130_HB_315_RH_N.html http://www.legislation.gov.uk/uksi/2013/239/contents/made